文献速递肝病消化道肿瘤与早癌

端粒长度决定肝细胞癌多样性,端粒酶依赖成为可靶向治疗方向

Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
PubMed 文献 · J Hepatol · 2020-12-15

该研究在1502例患者(978例肝细胞癌)中测量端粒长度并整合TERT改变及临床分子特征,发现衰老、肝纤维化、男性和过量饮酒是肝端粒磨损的独立决定因素,端粒长度与肝癌分子亚型及预后相关,抗TERT反义寡核苷酸在细胞系和异种移植模型中显示疗效。

要点

  • 衰老、肝纤维化、男性和过量饮酒是肝端粒磨损的独立决定因素。
  • 长端粒肝癌多呈TERT野生型、祖细胞特征和BAP1突变,短端粒肝癌富集非增殖类和TERT启动子突变。
  • 抗TERT反义寡核苷酸通过端粒缩短和DNA损伤抑制高增殖低分化肝癌细胞,支持TERT致癌依赖。

核心结论

  • 肝癌发生中端粒维持机制多样,与肿瘤进展和侵袭性相关,抗TERT反义寡核苷酸治疗揭示肝癌对TERT的致癌依赖,为临床试验提供临床前依据。

研究设计与样本

  • 测量1502例患者(978例肝细胞癌)肿瘤与非肿瘤肝组织端粒长度,整合TERT改变、表达及临床和分子特征。
  • 在26个细胞系体外和异种移植小鼠模型中评估抗TERT反义寡核苷酸的临床前疗效。

主要发现

  • 衰老、肝纤维化、男性和过量饮酒是肝端粒磨损的独立决定因素。
  • 长端粒肝癌常为TERT野生型,具有祖细胞特征和BAP1突变;短端粒肝癌富集非增殖类和体细胞TERT启动子突变。
  • 肝癌端粒长度稳定在约5.7 kb的窄生物学范围,类似非肿瘤肝,通过多种机制激活TERT表达。
  • 长端粒是侵袭性肝癌特征,与G3转录组亚类、TP53改变和不良预后相关。
  • 抗TERT反义寡核苷酸处理3至16周通过端粒缩短、DNA损伤和凋亡激活使12个细胞系增殖停滞,异种移植模型亦获疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Telomerase activation is the earliest event in hepatocellular carcinoma (HCC) development. Thus, we aimed to elucidate the role of telomere length maintenance during liver carcinogenesis. METHODS: Telomere length was measured in the tumor and non-tumor liver tissues of 1,502 patients (978 with HCC) and integrated with TERT alterations and expression, as well as clinical and molecular (analyzed by genome, exome, targeted and/or RNA-sequencing) features of HCC. The preclinical efficacy of anti-TERT antisense oligonucleotides (ASO) was assessed in vitro in 26 cell lines and in vivo in a xenograft mouse model. RESULTS: Aging, liver fibrosis, male sex and excessive alcohol consumption were independent determinants of liver telomere attrition. HCC that developed in livers with long telomeres frequently had wild-type TERT with progenitor features and BAP1 mutations. In contrast, HCC that developed on livers with short telomeres were enriched in the non-proliferative HCC class and frequently had somatic TERT promoter mutations. In HCCs, telomere length is stabilized in a narrow biological range around 5.7 kb, similar to non-tumor livers, by various mechanisms that activate TERT expression. Long telomeres are characteristic of very aggressive HCCs, associated with the G3 transcriptomic subclass, TP53 alterations and poor prognosis. In HCC cell lines, TERT silencing with ASO was efficient in highly proliferative and poorly differentiated cells. Treatment for 3 to 16 weeks induced cell proliferation arrest in 12 cell lines through telomere shortening, DNA damage and activation of apoptosis. The therapeutic effect was also obtained in a xenograft mouse model. CONCLUSIONS: Telomere maintenance in HCC carcinogenesis is diverse, and is associated with tumor progression and aggressiveness. The efficacy of anti-TERT ASO treatment in cell lines revealed the oncogenic addiction to TERT in HCC, providing a preclinical rationale for anti-TERT ASO treatment in HCC clinical trials. LAY SUMMARY: Telomeres are repeated DNA sequences that protect chromosomes and naturally shorten in most adult cells because of the inactivation of the TERT gene, coding for the telomerase enzyme. Here we show that telomere attrition in the liver, modulated by aging, sex, fibrosis and alcohol, associates with specific clinical and molecular features of hepatocellular carcinoma, the most frequent primary liver cancer. We also show that liver cancer is dependent on TERT reactivation and telomere maintenance, which could be targeted through a novel therapeutic approach called antisense oligonucleotides.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Ningarhari M, Caruso S, Hirsch TZ, et al. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target. J Hepatol. 2020. PMID: 33338512. doi:10.1016/j.jhep.2020.11.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。